The drug formulation of Adderall (both controlled and instant release forms) is:

Relative bioavailability is extremely sensitive to drug formulation.

That is, by an intrinsic property of the drug formulation, rather than by special mixing and handling.

Thus, the teratogenic right-handed thalidomide molecule can be omitted from present-day drug formulations.

By altering the composition of the shell and matrix, many drug formulations and ways of release can be achieved.

Especially are desired improvements in antitumor activity, toxicity profile, drug formulation and pharmacology.

Certain drug formulations include glycine to improve gastric absorption of the drug.

Treatment of active ingredient by special ways such as spherical crystallization can have some advantages for drug formulation.

This involves the optimization of the synthetic route for bulk industrial production, and discovery of the most suitable drug formulation.

Mr. Ko is a specialist in biological drug formulation and product development based on immunology.